尤其在生物医药产业布局上，逢时科技契合了行业发展机遇。发展海洋经济、保护海洋生态环境、加快建设海洋强国，是推动中国式现代化的有机组成和重 要任务。中央财经委员会第六次会议强调，要围绕新制造、新服务、新业态、新模式，加快推动传统海洋产业升级和战略性新兴产业发展，在海洋新能源、 海洋新材料、海洋生物医药及制品等新制造领域取得突破。我国"十五五"规划建议更明确提出，推动海洋经济高质量发展，加快建设海洋强国，加强海洋科 技创新，壮大海洋新兴产业。 高科技含量、高附加值的海洋生物医药产业是我国新兴产业的重要代表，也为破解陆地资源约束、实现产业升级提供了重要路径。在此背景下，逢时科技布 局生物医药产业，契合了时代发展节拍与行业趋势。 从2018年成立至今，这家以南极磷虾开发为核心的企业仅用7年，便完成"专精特新中小企业—山东省瞪羚企业—国家级小巨人"的"三级跳"，不仅低于入 选"小巨人"企业的平均成立年限，也成为所在海洋新兴产业快速发展的典型案例。 運 创 新 致 远 选对赛道，契合发展趋势 年轻的逢时科技之所以能在7年时间内实现跨越式发展，关键在于选对了发展方向。依托对南极磷虾的深度开发与高值化利用，逢时科技布局了海洋 ...

Core Viewpoint - The company, Fengshi Technology, is leveraging the abundant resources of Antarctic krill to innovate and upgrade its products from functional foods to health supplements, establishing itself as a leader in the industry with a strong focus on technology and innovation [1][4]. Group 1: Company Overview - Fengshi Technology has been recognized with multiple honors, including being named a national intellectual property advantage enterprise and a high-growth marine enterprise in Qingdao, showcasing its strong market position and brand value of 39.199 billion yuan [1]. - The company has invested in a transparent factory covering 18,000 square meters, featuring a GMP purification workshop, ensuring automated and traceable production processes [2]. Group 2: Industry Position and Innovation - The Antarctic krill is recognized as one of the largest biological resources on Earth, with a biomass of hundreds of millions of tons, and is praised for its high nutritional value, including high protein and omega-3 fatty acids [2][5]. - Fengshi Technology has achieved a "5-year 0-defect" quality gold standard from ORIVO, becoming the first and only company to do so, indicating its commitment to quality and international standards [3][5]. - The company has established a three-pronged innovation strategy: one-third from independent research and development, one-third through collaboration with marine research institutions, and one-third from overseas acquisitions [3]. Group 3: Future Directions - Fengshi Technology aims to deepen its research into the medicinal value of Antarctic krill, transitioning from food products to marine biomedicine, thereby enhancing its competitive edge in the market [4]. - The company is focused on integrating marine economy with biomedicine, contributing to the development of a new "blue quality productivity" in the industry [4].